FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/24/2023
Back to search
Official data from USPTO
DA NING TANG SINCE 1383
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
10/24/2023
Trademark type
Combined
Nice classes
5, 35
Filing date
07/08/2021
Registration date
06/13/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/13/2023
Last transaction
06/13/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CN
Examiner
HAN, DAWN L
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the portrait of a Chinese man in ancient clothing. To his left appears the Chinese character that transliterates to "FU", and to his right appears the Chinese character that transliterates to "SHAN". These all appear against a shaded and outlined circle background. Below this design appear three Chinese characters that transliterate to "DA NING TANG", with the wording "SINCE" to its left and "1383" to its right, all appearing on a banner design. Below these appears the wording "DA NING TANG". All the wordings in the mark appear in stylized font.
Holders and representatives
Holders
Taiyuan Da Ning Tang Pharmaceutical Co.,Ltd.
Representatives
John G. Tutunjian TUTUNJIAN & BITETTO, P.C.
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinal preparations for inflammationmetabolic diseasesendocrine diseasescardiovascular diseasescerebrovascular diseases and kidney diseases for humans; medicines made of Chinese traditional medicinal herbs; Chinese traditional medicinal herbs; medicinal liquoralcohol for medicinal purposes; medicinal preparations in the form of tablets for inflammationmetabolic diseasesendocrine diseasescardiovascular diseasescerebrovascular diseases and kidney diseases; antiparasitic preparations; anti-inflammatory ointment
Class 35
Retail store services featuring pharmaceuticalveterinary and sanitary preparations and medical supplies; retail and wholesale store services featuring medicine; retail and wholesale store services featuring pharmaceutical preparations; retail and wholesale store services featuring sanitary preparations; retail and wholesale store services featuring medical supplies; retail and wholesale store services featuring veterinary medicines; retail and wholesale store services featuring veterinary preparations; wholesale store services featuring pharmaceuticalveterinary and sanitary preparations and medical supplies
Publications
History of USPTO decisions and trademark events.
41 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
09/14/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
09/14/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/13/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/13/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/13/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/05/2023
GPNX
NOTIFICATION PROCESSED BY IB
03/29/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/28/2023
PUBO
PUBLISHED FOR OPPOSITION
03/28/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/15/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/15/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/08/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/08/2023
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/22/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
02/22/2023
ALIE
ASSIGNED TO LIE
02/16/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/26/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
01/26/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/26/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
01/26/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/26/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
01/24/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
01/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/23/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/22/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
12/22/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/22/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/19/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/19/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/19/2022
RFNT
REFUSAL PROCESSED BY IB
06/06/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/16/2022
RFRR
REFUSAL PROCESSED BY MPU
05/16/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/01/2022
CNRT
NON-FINAL ACTION WRITTEN
03/31/2022
DOCK
ASSIGNED TO EXAMINER
03/28/2022
MAFR
APPLICATION FILING RECEIPT MAILED
10/23/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/19/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/14/2021
Continuous trademark protection
Get notified about every new filing that threatens DA NING TANG SINCE 1383 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.